We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
-$1.13B
Cap. Flow %
-1.03%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,446
Increased
2,646
Reduced
3,048
Closed
1,267

Sector Composition

Rank Sector Weight
1 Technology 7.41%
2 Consumer Discretionary 6.04%
3 Financials 5.89%
4 Industrials 4.61%
5 Healthcare 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLX icon
7026
CALL
Protalix BioTherapeutics
PLX
$183M
$26K ﹤0.01%
+1,890
New +$17K
IMI
7027
DELISTED
Intermolecular, Inc.
IMI
$26K ﹤0.01%
+27,744
New +$29K
AWX icon
7028
Avalon Holdings
AWX
$10.4M
$25K ﹤0.01%
+10,882
New +$30.6K
PLUG icon
7029
PUT
Plug Power
PLUG
$3.26B
$25K ﹤0.01%
18,400
-7,000
-28% -$8.03K
PLUR icon
7030
Pluri
PLUR
$18.5M
$25K ﹤0.01%
255
+119
+88% +$11.6K
CNSY
7031
Cerenome, Inc. Common Stock
CNSY
$25.9M
0
CNSY
7032
PUT
Cerenome, Inc. Common Stock
CNSY
$25.9M
0
PGH
7033
CALL
DELISTED
Pengrowth Energy Corporation
PGH
$25K ﹤0.01%
24,500
-17,900
-42% -$22.2K
MTSL
7034
DELISTED
MER TELEMANAGEMENT SOLUTNS LTD
MTSL
$25K ﹤0.01%
42,720
-4,241
-9% -$2.48K
IFO
7035
DELISTED
INFOSONICS CORPORATION
IFO
$25K ﹤0.01%
46,633
-8,396
-15% -$4.5K
OPTT icon
7036
Ocean Power Technologies
OPTT
$55.4M
$24K ﹤0.01%
542
-1,339
-71% -$70.3K
PRSO icon
7037
Peraso
PRSO
$9.89M
$24K ﹤0.01%
+15
New +$30.1K
FLNA
7038
Filana Therapeutics
FLNA
$43.9M
$24K ﹤0.01%
+3,808
New +$17.3K
VGZ icon
7039
CALL
Vista Gold
VGZ
$339M
$24K ﹤0.01%
23,200
-15,800
-41% -$16.3K
AXU
7040
DELISTED
Alexco Resource Corp
AXU
$24K ﹤0.01%
15,847
-19,767
-56% -$33.7K
MBII
7041
DELISTED
Marrone Bio Innovations, Inc.
MBII
$24K ﹤0.01%
+12,482
New +$26.4K
MDSY
7042
DELISTED
ModSys International Ltd. Ordinary Shares
MDSY
$24K ﹤0.01%
29,340
+1,901
+7% +$1.74K
GSL icon
7043
Global Ship Lease
GSL
$1.51B
$23K ﹤0.01%
+1,919
New +$23K
INSG icon
7044
Inseego
INSG
$77.5M
$23K ﹤0.01%
1,086
-1,973
-64% -$54.1K
PERI icon
7045
Perion Network
PERI
$386M
$23K ﹤0.01%
+4,268
New +$23.6K
STRM
7046
DELISTED
Streamline Health Solutions
STRM
$23K ﹤0.01%
+1,495
New +$28K
AAU
7047
DELISTED
Almaden Minerals Ltd
AAU
$23K ﹤0.01%
+19,413
New +$21.1K
BIOC
7048
DELISTED
Biocept, Inc.
BIOC
$23K ﹤0.01%
+1
New +$17K
EVFM
7049
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$23K ﹤0.01%
+157
New +$20.4K
HLTH
7050
CALL
DELISTED
Nobilis Health Corp.
HLTH
$23K ﹤0.01%
13,600
-3,000
-18% -$6.24K

Similar funds

Ken Griffin's Q1 2017 Portfolio in Review

As of Q1 2017, Ken Griffin held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin's Q1 2017 filing shows 1,446 new, 2,646 increased, 3,048 reduced and 1,267 closed positions. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M. The largest sale was Alphabet (Google) Class A, an estimated $482M.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 5.7% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Ken Griffin's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Ken Griffin added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Ken Griffin's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Ken Griffin fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Ken Griffin's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Ken Griffin opened 1,446 new positions and closed 1,267 in Q1 2017.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.